Un vaccin par spray nasal bloquant la transmission de la COVID-19 développé à Tours

With no injection required and the ability to block transmission of the virus, the Tourangeau vaccine will be ready by 2024. It will use proteins other than Spyke, which has an unfortunate tendency to mutate. A non-invasive vaccine that could be particularly useful for vaccinating children and populations in emerging countries.